Differential expansion and survival of high and low avidity cytotoxic T cell populations during the immune response to a viral infection

Cellular Immunology

Volumn 201, Issue 1, 2000, Pages 58-62

  Alexander Miller, Martha A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS INFECTION; VIRUS RECOMBINANT;

EID: 0034630306     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1006/cimm.1999.1632     Document Type: Article

References (16)

1. Alexander-Miller M. A., Leggatt G. R., Berzofsky J. A. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl. Acad. Sci. USA. 93:1996;4102-4107.
2. Alexander-Miller M. A., Leggatt G. R., Sarin A., Berzofsky J. A. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J. Exp. Med. 184:1996;485-492.
3. Gallimore A., Dumrese T., Hengartner H., Zinkernagel R. M., Rammensee H. G. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J. Exp. Med. 187:1998;1647-1657.
4. Zeh H. J. III, Perry-Lalley D., Dudley M. E., Rosenberg S. A., Yang J. C. High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. J. Immunol. 162:1999;989-994.
5. Yee C., Savage P. A., Lee P. P., Davis M. M., Greenberg P. D. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J. Immunol. 162:1999;2227-2234.
6. Shen Z., Reznikoff G., Dranoff G., Rock K. L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158:1997;2723-2730.
7. Rotzschke O., Falk K., Stevanovic S., Jung G., Walden P., Rammensee H. G. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21:1991;2891-2894.
8. Restifo N. P., Bacik I., Irvine K. R., Yewdell J. W., McCabe B. J., Anderson R. W., Eisenlohr L. C., Rosenberg S. A., Bennink J. R. Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 154:1995;4414-4422.
9. Murali-Krishna K., Altman J. D. S. M., Sourdive D. J. D., Zajac A. J., Miller J. D., Slansky J., Ahmed R. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity. 8:1998;177-187.
10. Butz E. A., Bevan M. J. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity. 8:1998;167-175.
11. d-restricted cytotoxic T lymphocytes. J. Exp. Med. 173:1991;849-858.
12. Russell J. H., White C. L., Loh D. Y., Meleedy-Rey P. Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc. Natl. Acad. Sci. USA. 88:1991;2151-2155.
13. Ahmed R., Gray D. Immunological memory and protective immunity: Understanding their relation. Science. 272:1996;54-60.
14. Busch D. H., Pamer E. G. T cell affinity maturation by selective expansion during infection. J. Exp. Med. 189:1999;701-710.
15. Savage P. A., Boniface J. J., Davis M. M. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity. 10:1999;485-492.
16. Dutton R. W., Bradley L. M., Swain S. L. T cell memory. Annu. Rev. Immunol. 16:1998;201-223.